Hemlibra® is known to interfere with certain laboratory assays used to measure blood coagulation.
On April 10th, experts discussed what is involved in a telemedicine visit and provided a look at what is needed for a successful telemedicine visit.
NHF will update this page as more statements become available.
Developing such a treatment would necessitate plasma donations from many people who have fully recovered from COVID-19, and whose blood contains antibodies that can fight the coronavirus.
What you need to know about access to HTCs
On March 27th, experts from NHF answered your questions regarding changes in insurance in our townhall webinar: Insurance: Coping During COVID-19.
On March 20th, NHF’s President and CEO answered your questions about how COVID-19 affects our community.
Information and techniques you and your family can use to stay healthy during the COVID-19 pandemic.
A statement from Dr. Valentino addressing the concerns of the community regarding the rapidly evolving COVID-19 situation.
Due to the recommendations of local government, NHF's New York City staff will be working remotely until further notice. We will continue to work to serve the bleeding disorders community during this time.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car